Akron’s high-quality cGMP Recombinant Proteins offer the consistency, safety, and efficacy that empower today’s leading clinical and commercial cell therapy companies.
Akron’s proven blood products deliver safety and performance backed by robust and redundant supply. Because you can’t afford to compromise.
Capitalizing on our established platform for manufacturing cGMP-compliant, clinical-grade ancillary products, Akron is well-positioned to provide custom development and manufacturing to accelerate the commercialization of advanced therapies.
At Akron, we manufacture high-quality compliant cGMP plasmid DNA for pre-clinical, clinical, and commercial gene therapy and vaccine companies where material needs are 1+ grams.
London
We are excited to be attending this year's Allogeneic Cell Therapies Summit in London.
San Francisco, CA
Akron Bio is proud to be a sponsoring partner & roundtable facilitator at this year's US West Coast Advanced Therapies Xchange. Register today!
London
Akron Bio's Business Development Director Sara Padrell will be presenting at the CAR-TCR Summit on how to Build a Commercial-Ready Cell & Gene Therapy Supply Chain. Register today to listen to her speak!